Vendor:Cerebrum Corporation
Type | Corporation |
---|---|
Industry | Laboratory informatics software |
Headquarters | 250 S. Arizona Avenue, Suite #2, Chandler, Arizona, U.S. |
Number of locations | 1 |
Area served | United States |
Products |
Products list
|
Website | CerebrumCorp.com |
https://www.linkedin.com/company/cerebrum-corp/ |
Cerebrum Corporation develops and distributes laboratory informatics software solutions.
History
Cerebrum Corporation was formally founded in October 2009.[1]
Technology and products
LABdivus Clinical and LABdivus Research
LABdivus Anatomic Pathology is a laboratory information system (LIS) "that will give you the ability to increase your productivity and avoid the risk of error by accurately tracking specimens from accessioning through reporting."[2] The software can be installed locally or hosted in the cloud.
LABdivus Clinical Trials is LIS-like software similar to Anatomic Pathology but with more focus on clinical research labs, designed to "help you to mitigate the bottleneck between production and reporting and maintain your FDA inspection criteria."[3] The software can be installed locally or hosted in the cloud.
Features
The following feature list(s) is/are derived solely from public, freely-available online information the vendor provides. A lack of a "Y" does not necessarily mean that the product doesn't have that feature. The lack of a "Y" could mean:
|
Pricing
Additional information
References
- ↑ "Cerebrum Corporation". Arizona Corporation Commission Entity Search. State of Arizona. https://ecorp.azcc.gov/BusinessSearch/BusinessInfo?entityNumber=15564826. Retrieved 19 October 2020.
- ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 2.12 2.13 2.14 2.15 2.16 2.17 "Anatomic Pathology". Cerebrum Corporation. https://cerebrumcorp.com/anatomic-pathology/. Retrieved 19 October 2020.
- ↑ 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 3.12 3.13 3.14 3.15 3.16 "Clinical Trials". Cerebrum Corporation. https://cerebrumcorp.com/clinical-trials/. Retrieved 19 October 2020.